Fund Adds $12 Million to ADMA Biologics Despite Stock Down 58% Year-to-Date
B Group added $11.84 million in shares of ADMA Biologics (NASDAQ:ADMA) during the first quarter, increasing its stake despite a nearly 60% drop in share price over the past year. The fund's position now accounts for about 21.43% of its 13F assets under management.
Tickers: $ADMA
Topics: biotech SEC filings stock purchases